propafenone and Coma
propafenone has been researched along with Coma in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propafenone is an anti-arrhythmic drug used in the management of supraventricular and ventricular arrhythmias." | 5.36 | Propafenone poisoning--a case report with plasma propafenone concentrations. ( Dargan, PI; Jones, AL; Ludman, A; Ovaska, H; Spencer, EP; Wood, DM, 2010) |
| "Propafenone is an anti-arrhythmic drug used in the management of supraventricular and ventricular arrhythmias." | 1.36 | Propafenone poisoning--a case report with plasma propafenone concentrations. ( Dargan, PI; Jones, AL; Ludman, A; Ovaska, H; Spencer, EP; Wood, DM, 2010) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ovaska, H | 1 |
| Ludman, A | 1 |
| Spencer, EP | 1 |
| Wood, DM | 1 |
| Jones, AL | 1 |
| Dargan, PI | 1 |
Other Studies
1 other study available for propafenone and Coma
| Article | Year |
|---|---|
Propafenone poisoning--a case report with plasma propafenone concentrations.
Topics: Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Coma; Combined Modality Therapy; Drug | 2010 |